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Introduction
The evolution of technology can be an analogy to the ever-
expanding world of drugs and drug abuse. Technology used today is 
replaced by newer, more improved forms a few months later and the 
newest forms were never even heard of a hundred years ago.3 Drugs 
pursue a similar path, as thousands of new drugs are readily becoming 
available to the public, legally and illegally. People take drugs for 
different reasons including medical purposes, recreational uses, as a 
coping mechanism for daily life pressures, anxiety or stress and others 
use them to imitate human desires and pleasures.3 
The extensive information accessible to the public on the harmful 
effects of drug abuse, the laws prohibiting illegal taking of certain 
drugs and the future mental health issues that can a by-product of their 
misuse, doesn’t seem to stop the many people today that continue 
to exploit these licit and illicit drugs.3 A country’s legal position in 
relation to a drug can influence a person’s actions, as restrictions do 
not always take their desired effect, the excitement and risk of taking 
an illicit drug can be an influence, especially amongst the younger, 
inexperienced users.4 
Substances that affect both the mind and the body are commonly 
known as drugs. Cocaine and cannabis are two very common forms 
and are precisely entitled ‘psychoactive drugs’ by professionals in 
that field. This term relates to how the substance affects the body, 
particularly on the CNS and how they can alter a person’s mood, 
consciousness, perception and their behaviour.3 Recognising 
addiction and abuse of drugs as a chronic, reoccurring brain disorder 
by repeatedly pursing a drug, can help the understanding of their 
impact on society’s overall health.3
Stricter social policy strategies, addressing the current cocaine 
and cannabis abuse in the UK, can help diminish the health and 
social costs associated with it.5 It is difficult to determine the exact 
use and prevalence of an illicit drug in comparison to a legal drug, 
due to the absence of regulation and the vast differences in purity 
and potency, depending on the level of dealing it is discovered.6 
Epidemiology surveys including MTF and NHSDA, proceed to ask 
members of the public about their illicit drug usage and for obvious 
reasons many people are usually unwilling to give this information 
up, thus not allowing for adequate detail or information when creating 
a representative sample for a population.6 Treatment and prevention 
of drug abuse in the UK spans between school, family and youth 
programmes, to treatment services involving agents to help reduce the 
addictive effect of a drug and to help with cravings during abstinence 
syndrome during treatment.7 
This paper explores the topics mentioned, and discusses the overall 
history, effects and prevalence surrounding the abuse of cocaine and 
cannabis in the UK. In addition to also considering current prevention 
and treatment programmes and evaluating their effectiveness using 
relevant literature.
Discussion
Psychological effects of drug abuse
Body systems are constantly changing to establish balance and 
equilibrium, for optimal functioning of all vital organs and systems 
throughout the body. Drugs can interfere with this balance and cause 
drug-induced disruption. For example, stimulants can dangerously 
increase the heart rate and blood pressure and cause a heart attack. 
Forensic Res Criminol Int J. 2020;8(1):31‒40. 31
©2020 O’Hagan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which 
permits unrestricted use, distribution, and build upon your work non-commercially.
Cocaine and cannabis abuse in the UK: psychological 
effects, social prevalence and treatment
Volume 8 Issue 1 - 2020
Andrew O’Hagan, Zoe Shiels
Nottingham Trent University United Kingdom
Correspondence: Andrew O’Hagan, Nottingham Trent 
University School of Science & Technology
Erasmus Darwin, Room 230, Nottingham Trent University, 
Clifton Lane Nottingham NG11 8NS, Direct Line 01158483153, 
United Kingdom, Tel 07850875563, 
Email 
Received: January 10, 2020 | Published: January 23, 2020
Abstract
Cocaine is amongst the most highly addictive drugs used worldwide and its expanding 
demand in the UK is causing it to become an increasingly, problematic drug.1 Cannabis 
abuse is a large scale phenomenon and its growth and cultivation within the UK has 
developed greatly throughout the years.2 Both cocaine and cannabis since their first use 
and identification, have both been found to have many different effects and long term 
risks to health, which is the reason for their illegality. This paper views aspects of their 
history and origin and their psychological effects on a user, both short-term and long-term. 
Using relevant statistics, this paper also considers how age, sex, environments and social 
situations can cause different levels of abuse of these drugs. A thorough understanding 
of the effects and prevalence of these two major illicit drugs, can allow treatment and 
prevention programmes to be constructed with a clearer understanding of their target 
groups.3 This review pursues a conclusion on whether these programmes can be sufficient in 
not only reducing the abuse of these illicit drugs, but to also bring about social change and 
to prevent subsequent divesting effects including homelessness and suicide from occurring 
as frequently as they do today.
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prevention, illicit drugs
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Cocaine is a psychoactive stimulant that can cause this affect.8 CNS 
depressants however, can cause opposing affects, they can diminish 
brain activity resulting in unconsciousness and loss of breathing 
reflexes. Several drugs of abuse have the ability to exert actions that 
mimic the same neuronal circuits as natural reward pathways do 
throughout the body.9 This is compatible with positive reinforcement 
and both drugs of abuse, as well as natural rewards like food and sex, 
that activate the mesolimbic dopaminergic pathway, causing reward 
positive conditioning in the body.9,10 A systematic diagram of the 
reward mechanism is shown below.9 
Tolerance and dependence are adaptive processes to aid the body 
in protecting against potential harm and disruption, caused by drug 
abuse. Tolerance occurs when a response to the same dose of drug 
decreases, with repeatedly, higher dosage. There are two main types 
of tolerance including drug disposition tolerance, which is increased 
metabolism of the drug and therefore increased drug elimination.9 
Pharmacodynamic tolerance is the other form, where the drug and 
receptor affinity is altered or receptor numbers are lowered, resulting 
in decreased binding of the drug and its effects. Figures 1&2.9 
Figure 1 A reproduced flow diagram illustrating the withdrawal mechanism 
of a drug.9
Figure 2 A reproduced flow diagram illustrating the reward mechanism of 
a drug.9
The user can develop dependence if they stop administering 
the drug and the systems in the body become unbalanced, causing 
withdrawal. A systematic diagram of the withdrawal mechanism is 
shown in Figure 3.9 Withdrawal symptoms of a drug tend to oppose 
their reward symptoms.3 
Figure 3 1885 Advertisement for cocaine containing drops.21
Reward and withdrawal effects caused by a drug also depend on 
the route of administration. This differs with the type of drug and can 
also effect the speed at which a drug enters the bloodstream and brain, 
determining the potency of its effects.6 Table 1 below displays types 
of drug administration. 
Table 1 The mechanism a drug undertakes when administered using different 
sites and routes3,6
Route of 
administration Mechanism
Intravenous (IV)
Example: Heroin - Rapid effects of the drug, 
bolus injections produce high concentration of 
the drug, first in the right side of the heart and 
pulmonary vessels and then to the systematic 
circulation.3
Nasal
Example: Cocaine – Avoids first pass metabolism 
in the gut, goes rapidly into nasal veins and 
capillaries, absorption takes place through the 
mucosa overlying the nasal-associated lymphoid 
tissue.
Inhalation
Example: Opiates – Similar mechanism to nasal 
administration, but does eventually undergo first 
pass metabolism.3
Oral
Example: LSD – Easiest route of administration, 
but the slowest to cause an effect. Little 
absorption until it enters the small intestine, 
however, some drugs applied to the buccal 
mucosa or under the tongue are absorbed 
directly from the mouth.3
Peripheral IV 
(subcutaneous)
Main action is paralysis of the periphery, not 
being able to move is masked by the reward/
pleasure pathway. Faster effect than oral 
administration and rate of absorption depends 
on the site and local blood flow.3
Cocaine and its history
In the past, cocaine use was promoted by medical journals and 
followers of Freud, the founder of psychoanalysis and was seen 
as useful in medicines and tonics for its anaesthetic properties.11 
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However, It soon became a concern when its adverse effects were 
identified and drug became part of the Dangerous Drugs Act of 1920.11 
It later became a Class A controlled drug in the 20th Century, under the 
Misuse of Drugs Act (MDA) 1971.8,12 
Cocaine originates from Colombia, Peru and Bolivia and is from 
the coca leaves of the Erythroxylum coca plant.8 Its first discovery 
was in the 1850’s as the ‘miracle drug’, before its adverse effects 
were fully understood.8 It was incorporated into every-day products 
including tooth paste drops, which is the advertisement featured in 
Figure 3 and Coca-Cola, which originally contained approximately 
9mg of cocaine. In later years, more people and manufacturers became 
increasingly aware of cocaine’s toxicity and its mechanism of action 
and it was removed from these types of products.13
The mechanism and effects of cocaine
Cocaine has the ability to establish a strong, physical addiction and 
is known as one of the most dangerous illicit drugs ever discovered.14 
It primarily works on the nucleus accumbens section of the limbic 
system, in the brain.15 It causes a build-up of dopamine due to the 
inhibition of transporters, which blocks the reuptake of dopamine, 
noradrenaline and serotonin.8 The build-up of noradrenaline activity 
increases the effects of the user’s sympathetic nervous system and 
alters their cardiovascular activity.3 
Administering cocaine by either snorting, smoking or injecting 
causes build-up of dopamine, increasing the stimulation of cells in the 
nucleus accumbens and resulting in a feeling of intense pleasure and 
satisfaction. This mechanism gives users an intolerable desire to use 
again, to re-experience this sensation.16 Its effects however depend 
on the type of cocaine and its purity and potency. The purity can 
differ throughout the dealer chain, as majority of ‘street’ cocaine is 
cut by cheaper fillers like talcum powder and amphetamines, making 
it only 50% pure in order to for an increased personal gain for the 
dealer.17 The alkaloid form can be made into a paste by heating it with 
hydrochloric acid, to produce cocaine hydrochloride and this causes 
more potent effects on the user.8 Crack cocaine developed in the mid 
1980’s, is made by boiling cocaine with a hydrochloride and baking 
soda solution, to form a rock composition, free of its water-soluble 
base. This form also produces stronger, more harmful effects to the 
user when administered.8 
Scientific studies of cause, distribution and control, have 
demonstrated that polysubstance abuse often occurs in association 
with cocaine abusers, which can subsequently lead to the abuser being 
exposed to further adverse effects and risks.19 Cocaine causes short but 
instantaneous bursts of energy, strength and pleasure and are greater 
than that achieved during normal activities.19,20 
A high produced by cocaine can cause psychotomimetic effects 
including euphoria, hyperactivity, restlessness, enhanced confidence, 
reduced appetite and is occasionally followed by feelings of 
discomfort and depression.8,22 
With considerable exposure to cocaine, desensitisation begins 
to occur of the dopamine D1-like receptors in the reward pathway, 
reducing the usual reinforcements made by the drug.8 This dopamine 
depletion theory may explain why cocaine is increasingly administered 
by a user, who eventually builds up a tolerance, resulting in higher 
doses being administered in order to experience the same effects.8,14,15 
Physical withdrawal effects during abstinence of cocaine are more 
minor than that of long-term use of CNS depressants and are not 
considered life-threatening. However, chronic cocaine users are 60% 
more likely to commit suicide than a non-user. Withdrawal symptoms 
include, sleep abnormalities, cravings, agitation and anhedonia, which 
is decreased ability to feel pleasure.3 
In 1860, Albert Niemann who was a PhD student at the time, 
explored the extraction of cocaine from the coca leaves and identified 
its capability to impose anaesthetic effects, after applying it to his 
tongue and feeling it grow progressively numb.23 Clinical advances 
have allowed cocaine to be used in some local anaesthetics, as it has 
the ability to reduce bleeding during vasoconstriction and can numb 
an area topically.3,8 Confined applications are relatively safe, however 
cocaine can still enter the bloodstream and in people with vulnerable 
body systems, can cause CNS stimulation, toxic psychosis and 
sometimes death.3 Tetracaine, epinephrine and lidocaine are examples 
of anaesthetics containing cocaine derivatives, concentrations of 
these can also be combined to apply to skin and reduce the pain of 
facial and scalp lacerations.3,8 In other scientific reviews, the dangers 
of cocaine have been further illustrated, with there being cases of 
acute myocardial infarction and cerebrovascular accident in relation 
to cocaine use. Additionally, it has been recognised that excessive 
cocaine use can also be related to ruptured aorta, cardia arrhythmia 
and sudden death.14
Cannabis and its history
Cannabis is the world’s most widely used illicit drug, with 
evidence of its use dating back to the Neolithic period, around 
4000BC.24 It is also the third highest drug to take concern of addiction 
treatment services.25 Although cannabis is currently a Class B drug, 
under the Misuse of Drugs Act 1971, it still has a maximum sentence 
of up to 14 years of imprisonment for supplying the drug, yet large 
numbers of people still knowingly risk the consequences.12,24 At the 
time of its classification of being a Class C drug, it was argued that 
cannabis has a strong relationship with mental illness, in particular 
with schizophrenia. Further legal control would be needed in order to 
help reduce its prevalence and its associated harmful effects, thus it 
was reclassified in 2009 as Class B.26 Cannabis originates from China, 
in 2800 B.C. and was primarily used for medical and recreational 
purposes. Surprisingly, it wasn’t until the 19th century that it made its 
way to Europe.27 It is produced from the dried flowers and hemp from 
the plant Cannabis sativa and can come in several forms including 
marijuana, cannabinoid oils and solid resin hashish.28 
Mechanism and effects of cannabis
There are 421 different chemicals in cannabis, Δ-9-
Tetrahydrocannabinol (THC) being the primary psychoactive agent.3 
THC makes up 1-10% of the weight of marijuana and causes the 
characteristic ‘high’ many users desire.2 Cannabidiol is a non-
psychoactive component of cannabis, it has the ability to influence 
THC and can induce therapeutic effects like anti-inflammation.29 
Both THC and cannabidiol are secreted from the same glands called 
trachoma’s, contained within the plant.30 Its toxicity and effects are 
induced predominantly in the areas of the brain that are abundant in 
cannabinoid CB1 receptors, including in the hippocampus, cerebellum, 
amygdala, the prefrontal cortex and striatum in the brain.31 
This drug can be administered using various inhalation and oral 
methods and it causes a depressant action, rather than a stimulatory 
one. It depresses the central nervous system, causing psychotomimetic 
effects like hallucinations, altered perception and behaviours, increased 
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relaxation and sharpened sensory awareness, which intensifies colours 
and sounds. Altering a person’s perception and causing hallucinations 
can cause a lot of cannabis users to also experience a sense of 
paranoia and this can subsequently lead to increased risk of injury. 
Over-time the use of cannabis can cause effects centrally to the body, 
including impairment of short-term memory, simple learning, motor 
coordination and peripheral effects, including analgesia, tachycardia, 
vasodilation and bronchoconstriction. 
Adverse effects
After excessive use of cannabis, unfortunate adverse effects 
may occur including reduced testosterone and sperm count, apathy, 
underachievement and mental illnesses, including schizophrenia 
can develop after long term psychological effects.9 The prevalence 
of people with mental health problems increase by 30-40% when 
they’re dependant on drugs or alcohol.32 Long-term and chronic 
use of cannabis can cause brain morphology alterations and volume 
decrease in the hippocampal region of the brain, which correlates with 
the psychotic symptoms associated with schizophrenia.33 
A considerable portion of people that have the disorder 
schizophrenia, also smoke cannabis at high doses, however there 
are very few studies relating to this relationship, so research is still 
needed to make this a solid connection.34 One explanation is that the 
human endocannabinoid (ECB) system can be disrupted in vulnerable 
individuals, increasing their risk of developing schizophrenia when 
exposed to cannabis.35 
Epidemiological research has suggested that regular use of 
cannabis, particularly during adolescence into adulthood, can increase 
the likelihood of these adverse effects on the user.36 Tolerance and 
dependence rarely occur when it comes to use of cannabis, however 
there is evidence that increased sensitisation can occur and withdrawal 
symptoms mimic that of alcohol abstinence, including irritability and 
nausea.9 Cannabis can also be used therapeutically, due to its non-
psychoactive component cannabidiol, which in today’s society is 
readily incorporated in vape oils for peoples personal use. It can also 
be an anti-emetic drug during cancer treatments, including Nabilone 
which contains cannabis derivatives. Additionally, it can be used to 
increase a patient’s appetite, causing anti-wasting effects during an 
illness. Sativex is a nose and mouth spray that contains THC, that 
helps reduce pain and sleep disturbance, for patients with Multiple 
Sclerosis.9 Figure 4 shows a what a cannabis plant looks like and this 
was one seized by Derbyshire Constabulary.2 
Figure 4 Cannabis plant seized by Derbyshire Constabulary.24
Prevalence of drug abuse 
In the UK, estimating the number of individuals that use illicit 
drugs, where they acquire the drugs and how much they consume, is 
an ongoing challenge.37 The Home Office, the British Crime Survey 
(BCS), the Scottish Executive and the Northern Ireland Office conduct 
regular household surveys regarding peoples crime experiences and 
questions surrounding drug use. These help provide a measure of 
prevalence of drug misuse, in a generalised population of the UK. 
National and household surveys can also help society formulate drug 
use policies and to identify specific groups within the population that 
are at greatest risk.38
Consequentially, this data can then be used to produce targeted and 
effective prevention and treatment programs.39 In order to gather this 
information accurately in relation to the population, there must be a 
level of compliance from the respondents, as nearly half of the reports 
of drug use are illegal and thus they would be admitting to violating 
the law.37 Accuracy of these surveys are also limited in estimating the 
heavier users of illicit drugs that maybe homeless, not in permanent 
residency and users in prisons.40 Table 2
Drug use in the UK has declined comprehensively when looking 
at the level it once was 10 years ago. However, cannabis still remains 
the most commonly used illicit drug, with powder cocaine being 
the second most prevalent and most used stimulant in the UK.41 In 
2016, it was stated by Dr Gillian Taylor, who is a member of Teesside 
University, that domestic wastewater tests have indicated that Class 
A drugs residues, specifically cocaine, are higher in some parts of 
Teesside, than in some major European cities like Paris and Berlin.42 
National Prevalence and trends in illicit drug use 
In 2013/14, 9% of 16-59 year old’s in England and Wales used 
illicit drugs in the last year.43 
It is evident from table 2 that cannabis and powder cocaine have 
the highest reported use in the years 2009 to 2014. Based on the 
survey data and statistics, these two drugs are the most prevalent 
among users, between the ages of 16-59. Cannabis has the highest 
prevalence recorded within this time frame and it has also been found 
to be the drug that causes most drug associated arrests in the UK. 
Table 2, Figures 5&6.44
It is clear from Figures 5&6 that the average percentage of people 
that used cannabis in this time period, is a lot higher than that of 
cocaine and the prevalence of cocaine and cannabis use is the highest 
within the age group 20-24 years. 45 Social factors can have a large 
influence with the risk of drug use, including a troubled family 
life, mental health, employment, educational attainment, early drug 
use and the n biology of a person feeling pleasure can increase the 
likelihood of that person to continue using.46 
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Table 2 Reproduced table showing the percentage of 16-59 year old’s, in England and Wales, that reported use of illicit drugs from 2009-201443
Drug Type 2009-2010
2010-
2011
2011-
2012
2012-
2013
2013-
2014
Stat. Sig. Change (2013-
14/2003-14)
Stat. Sig. Change (2013-
14/2012-13)
Cannabis 6.5 6.7 6.8 6.3 6.6 Decrease -
Powder Cocaine 2.4 2.1 2.1 1.9 2.4 Increase -
Ecstasy 1.6 1.4 1.4 1.2 1.6 Decrease Increase
Amphetamines 0.9 1 0.8 0.6 0.8 Decrease -
Ketamine 0.5 0.6 0.6 0.4 0.6 - Increase
LSD 0.2 0.2 0.2 0.2 0.3 - Increase
Opiates 0.2 0.2 0.3 0.1 0.2 - -
Crack Cocaine 0.2 0.2 0.1 0.1 0.1 - -
Heroin 0.1 0.1 0.1 0.1 0.1 - -
Figure 5 A graphical representation of the prevalence of cocaine use of people aged between 16-59 by age group, from the years 2013/14 to 2016/17. In England 
and Wales.43
Figure 6 A graphical representation of the prevalence of cannabis use of people aged between 16-59 by age group, from the years 2013/14 to 2016/17. In 
England and Wales. 43
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Prevalence due to personal characteristics
There are several suggested reasons why young people in the 
21st century are becoming increasingly exposed to drug use and 
are becoming more inclined to take drugs. The main reasons for 
this includes enjoyment, as it can be considered pleasurable for 
users.45 Their environment can have a large influence, as production 
and misuse of drugs tends to thrive in communities suffering from 
deprivation involving high levels of unemployment, low quality 
housing and poorly resourced infrastructure and local services. 
Curiosity and rebellion can also be their motivation to abuse drugs, 
as experimentation and attention seeking are stereotypical traits of 
young people. Lastly, a coping mechanism can be a reason why young 
people turn the use of drugs, due to extensive life and social pressure 
young people face today. Some see drug use as a distraction from their 
physical or emotional pain. Figures 7&8.41 
Figure 7 A graphical representation of the estimates of 2016 cannabis use 
among young adults (16-34 yrs), separated by gender in England and Wales.41
Figure 8 A graphical representation of the Estimates of 2016 cocaine use 
among young adults (16-34 yrs), separated by gender in England and Wales.41
Gender
Gender also has a role in the prevalence of drug misuse, as in 2013-
2014, 76% of the national frequent drug users were male. It has been 
seen that the risks associated with taking drugs are not considered 
fully by men compared to women, for example 27% of men believed 
it was safe to smoke cannabis and only 15% of women agreed.43 Sex 
differences are introduced at different stages of drug abuse from 
initiation to abstinence, with females typically administering a drug at 
a lower concentration to a male upon their initial dose.47 
Social norms can be a prevailing issue, particularly for women 
that abuse drugs and become addicts, as it effects the expectations of 
their gender and role as a woman. Social expectations surrounding 
women still have ongoing stereotypes attached to them, including 
women must be respectable and remain civilised and retain their 
decorum.11 However, these are not necessarily reasons why women 
may less frequently abuse drugs than men, they have just been 
norms surrounding women in certain social groups and countries for 
centuries.
Ethnicity
Drug use and abuse also varies with ethnicity, young adults with 
dual heritage having the highest percentage of reporting’s at 17.1%, 
white young adults accounting for 9.1% and 5.8% of young adults 
identified as black, between the years 2013-2014.43
Sexual orientation
Sexual orientation is also a consideration when looking a drug use 
prevalence, as the highest level of use tends to be people who identify 
as homosexual or bisexual and are predominantly male. Overall, 8.1% 
of people who used drugs between 2013-2014 were heterosexual, 
leaving the remaining percentage identifying as homosexual or 
bisexual.43
Prevalence and house-hold income
House-hold income also has an influence on not only the 
prevalence of drug abuse, but also the type of drug being used. Table 
5 below shows the prevalence of cocaine and cannabis use, in relation 
to increasing household income, between the years 2016-2017.43 Table 
5 A reproduced table of the proportion of 16 to 59 year olds reporting 
the use of drugs, by house hold income, in 2016/17.43
It is evident that with higher income, there is a significant decrease 
in the use of cannabis and an increase in the use of cocaine when 
entering the £50,000 and over achieving house-holds.43 In a study 
carried out by Gill and Michaels, their results suggested that some 
people that consume illegal substances may do so to manage workplace 
stress and emotional difficulties, which can heighten productivity in 
the short-term.48 In another recent study by Van Ours, the wage effects 
of cannabis use of prime-age males in Amsterdam were analysed. It 
was seen that cannabis use had a negative effect on wages and wage 
loss was greater for people who initiated their consumption early in 
life.49 These studies can be linked to the data in Table 5.
Prevalence and social activity
Varying environments and lifestyle choices can also have an impact 
on a person’s usage of drugs, two environments have been looked at 
with a comparison of the number of visits people made in one month, 
with their percentage of drug use. As shown in both Tables 3&4, 
there is a correlation between increased visits to pubs and nightclubs 
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and a higher percentage of people using cocaine and cannabis, with 
nightclub visits having the highest frequency of drug use.43
It is evident from Tables 3&4, that with increased visits to 
nightclubs in particular, as well as to a pub in one month, can have a 
significant effect on the level of drug abuse.43 
Table 3 A reproduced table of the Proportion of 16-59 year olds reporting 
use of drugs by frequency of pub visits in one month, in 2016/1743
Type of Drug 2016/17
Powder Cocaine 2.3
None 0.6
1 to 3 visits 1.8
4 to 8 visits 5.2
9 or more visits 10
Cannabis 6.6
None 4.3
1 to 3 visits 6.2
4 to 8 visits 10.5
9 or more visits 16.3
Table 4 A reproduced table of the Proportion of 16-59 year olds reporting 
use of drugs by frequency of nightclub visits in one month, in 2016/1743
Type of drug 2016/17
Powder Cocaine 2.3
Under 10,000 2.1
10,00-19,999 1.8
20,000-29,000 1.5
30,000-49,999 2
50,000 and over 3.2
Cannabis 6.6
Under 10,000 12
10,00-19,999 7.5
20,000-29,000 6
30,000-49,999 5.6
50,000 and over 5.7
Table 5 A reproduced table of the proportion of 16 to 59 year olds reporting 
the use of drugs, by house hold income, in 2016/1743
Type of Drug 2016/17
Powder Cocaine 2.3
None 1.5
1 to 3 visits 6.8
4 or more visits 16.1
Type of Drug 2016/17
Cannabis 6.6
None 5.1
1 to 3 visits 17
4 or more visits 26.6
Social consequences
There are several social consequences formed by the misuse of 
drugs, including the unclear explanation of the causal pathway between 
cocaine and aggression.50 However, through a study by Macdonald, it 
was determined that cocaine plays a significant role in the multi-causal 
explanation for violence surrounding drug abuse.50 Crime rates can 
be elevated in areas with a higher prevalence of drug movement and 
abuse, as people that become dependent on drugs may steal to fund 
their addiction and up to half of all money-orientated crime is drug-
related.43 Drug misuse and abuse can be the causal or contributing 
factor for homelessness, with approximately 80% of people who 
become homeless start using at least one new drug. The continuing 
abuse of drugs when homeless is likely to feed an addiction and as 
a coping mechanism to revert their minds from the reality of being 
homeless. The misuse of drugs accounts for over a third of deaths of 
homeless people each year.43 Drug misuse can have a dramatic effect 
on families, with drug dependent parents effecting their children’s 
wellbeing and upbringing. The abuse of drugs can reduce a parents 
competency to provide necessary practical and emotional care, which 
can lead to reduced educational achievement and attendance, mental 
health problems and increased risk to the children becoming involved 
with drug misuse themselves.43
Treatment and prevention
Addiction is a complicated process, especially when seeking 
treatment. Cravings for a drug repeatedly remind the person that 
maybe one more time won’t hurt.3 Then the body goes into a state 
of depression, where the user no longer feels or acts like themselves, 
because their body requires the chemical properties of the drug to feel 
whole again. Individual, interpersonal, societal and environmental 
factors all influence a person’s abuse of a drug in some way. Thus, 
acknowledging this when producing prevention and treatment 
programmes can allow the individual struggling with addiction to deal 
with all the different pressures surrounding them.3
The UK has relatively high rates of crack cocaine and opiate 
misuse compared to many western countries, however it also has a 
higher proportion of drug abusers using treatment services.41 Adult 
misusers often claim that opiates and stimulants like cocaine are their 
biggest problems with misuse and addiction, with younger people in 
the population reporting cannabis and psychoactive tablets are their 
primary problem. Studies and reports estimating high-risk drug use 
in the UK, can aid the identification of the extent of drug misuse and 
drug issues that need to be faced. Data from first-time entrants to 
specialised treatment centres can be considered and can give an idea 
of the type of drug being misused in that area and where drug abuse 
must be combatted.41 Currently in the UK, first-time clients joining 
treatment centres to seek help are commonly cannabis users, followed 
by cocaine users, with a higher proportion of males entering treatment 
in 2016, shown in Figure 9.41
Table continue
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Figure 9 A graphical representation of the proportion of users separated by 
gender, from the 29350 entrants in 2016 that entered treatment for cannabis 
use. 41 
Prevention
Drug prevention can be separated into three levels, which were 
originally classified by Mrazek and Haggerty in 1994.52 Firstly, 
primary drug prevention programs which are either nonusers who 
need advice and prevention against potential drug use or helping at-
risk people that maybe surrounded by the use of illicit drugs, to avoid 
their development into use and addiction.3,7 This involves affective 
education, counselling and strengthening families and community 
support systems. Secondary drug prevention programs involve 
identifying harmful substance use prior to the advancement to the 
dangerous problems with abuse, or intervening in early stages of drug 
abuse. These programs incorporate identification of abuse subgroups 
and individual diagnosis, with sanctions developed within schools 
and communities. Lastly, tertiary drug prevention programs focus 
on direct intervention of addicted and dependant users, who are in 
need of treatment.3,7 The reality of drug prevention should enhance 
protective factors and reverse or reduce risk factors associated with 
drug use and abuse.52 Predominantly targeting young people, social 
norms, skill development and interaction with peers and social life.53
Risk-factors surrounding drugs and their abuse can make younger 
people and children more likely to later use and abuse drugs. Thus, 
family, schools and community based programs are very important in 
tackling drug prevention are key to help enhance family relationships 
and parenting skills, whilst addressing the risks through academic 
and social learning.7 Community prevention programs can enable 
combining family-based and school-based programs, which can make 
prevention more effective overall.54
Treatment
Treatment in the 1980’s involved detoxification programmes, 
involving barbiturates were common when treating withdrawal from 
stronger drugs like cocaine, to allow for a slower, safer withdrawal.55 A 
treatment method involves taking sufficient quantities of antagonistic 
drugs, including Nalline, Naltrexone and Cyclazocine, to cause 
the narcotic to pose less harmful effects. Other social methods of 
drug treatment that are still commonly used today include narcotic 
anonymous meetings and self-help groups, which involve investment 
of time, effort and funding in order to help support people with 
problems of drug abuse and addiction.55 Over the past 20 years, the 
government has highlighted the role of treatment as not only helping 
the current abusers, but also its importance in reducing the prevalence 
of drug dependence throughout the UK. The expansion in the scope 
for different treatment services was initially promoted by the National 
Institute for Health and Clinical Excellence and the vast amount of 
evidence supporting its effectiveness has allowed treatment and 
prevention in the UK to continue to grow.37 
In relation to treatments developed in the 1980’s, maintenance 
prescriptions of methadone, buprenorphine and naltrexone are still 
regularly used to help detoxify the symptoms of withdrawal when 
reverting from highly addictive substances.56,57 Due to the powerful 
reinforcement disposition cocaine has once inside a user, effective 
treatment to reduce its addictive nature is not straight-forward. 
Common targets for the treatment of cocaine abuse involves symptoms 
of abstinence syndrome, cravings and anhedonia and sub sequentially 
several agents have been discovered that are effective in limiting and 
delaying their actions, including carbamazepine bromocriptine and 
amantadine. Figure 10.18,41 
Figure 10 A graphical representation of the proportion of people in the UK 
that entered treatment in 2017 and their primary drug of abuse. 41
It is clear from figure 10 that although cannabis is the most widely 
used illicit drug in the UK, in 2017 it was the second primary drug for 
people that entered treatment services.41
Modern approaches for clinical treatment of cocaine 
and cannabis abuse
Drug treatment is effectively well-delivered in the UK, the current 
treatment interventions have shown evidence of producing a positive 
effect on levels of drug use in the UK, criminal offences surrounding 
drug use, dependence and also allowing many patients to have long-
term sustained abstinence51 Agents that have an effect on specific 
components of the dopamine system, have the potential to be successful 
in managing cocaine abuse and can help reduce cravings during an 
abstinence syndrome, that many abusers experience during treatment 
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programmes.18 Pilot studies into the treatment of cocaine took place in 
2004 and it involved the use of topiramate for the treatment of cocaine 
dependence.58 It affected GABA and glutamatergic neurotransmission 
and has the ability to reduce properties and the craving for cocaine. 
Topiramate, which is commonly used as an anticonvulsant, increases 
the levels of GABA in the cerebral area of the brain and inhibits 
glutamatergic activity at AMPA/kainite receptors, which in turn can 
help treat cocaine dependence.58 Increasing use of cannabis in the UK 
allows further grounds for research into medications and treatment 
for its abuse. When analysing its mechanism of abuse, the primary 
target is the psychological dependence it produces, rather than the 
physical dependence.59 The development for new treatment drugs 
have involved the use of homomeric α7 nicotinic receptors as targets. 
In a systematic study, the administration of selective α7 nicotinic 
acetylcholine receptor antagonist methyllycaconitine (MLA) in rats, 
blocks the ability of the main active ingredient in cannabis THC to 
cause an effect, thus reducing drug-related psychological effects of 
the cannabis, even at low doses.59–63 
Conclusion
This literature review confirms that substance abuse continues 
to be a serious problem in the UK, especially among the younger 
generations. It has become apparent that is a vast amount of research 
and information surrounding their effects and prevalence, has 
allowed prevention and treatment services to be increasingly targeted. 
However, without addressing the youth drug culture accordingly, the 
prevention of dependence and addiction will continue to evolve. As 
discussed, social prevalence estimations can be limited due to the lack 
of permanent housing for some drug dependents and also the violation 
of the law surrounding the declaration of their abuse of illicit drugs 
in house-hold and national surveys.37 Over the long-term, prevention 
has been unsuccessful in reducing the early initial drug use, which 
currently tends to be where dependence derives from. However, there 
is strong evidence of treatment programmes currently being effective 
in the UK, with the aim to reduce the damage caused by drug abuse.54 
It has been confirmed by The National Institute for Health and Care 
Excellence (NICE) that the increasing investment into services 
available for drug treatment will be cost-effective.54,56,57 
Conclusively, the expansion of research into the adverse effects 
of substance abuse, as well as targeting certain areas of particularly 
higher prevalence, is the key to the evolution of preventing and the 
reducing the number of people abusing drugs. Thus, consequently 
reducing the harmful impact they have on people’s health and 
wellbeing. Even though it is evident that the improvements in the 
prevention and treatment of both cocaine and cannabis are some-
what effective in helping current abusers, the main issue that needs 
addressing involves the influenced youth culture of today, who are 
most vulnerable and exposed to the use and exploration of drugs. 
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